ArticleLeukemia2018

CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC.

I Tirado-Gonzalez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.